Thy1-CreERT2
品系全名
C57BL/6JSmo-Thy1em1(Kozak-CreERT2-WPRE-pA)Smoc
目录号
NM-KI-231054
品系状态
活体
基因信息
基因名
Thy1
品系描述
验证数据
Fig1. Detection of tdTomato expression on CD90+ cells in BM, spleen and blood.
In tamoxifen-treated HE/HE Thy1-CreERT2/R26-CAG-LSL-tdTomato mice, most CD90+ cells were tdTomato+ in bone marrow (~70 %), spleen (~90 %) and blood (~95 %).
Fig2. Detection of CD90 expression on tdTomato+ cells in BM, spleen and blood.
In HE/HE Thy1-CreERT2/R26-CAG-LSL-tdTomato mice, most tdTomato+ cells were CD90+ in bone marrow (~60 %), spleen (~90 %) and blood (66.5~89.4 %).
b
Fig3. CreERT2 mediated recombination in brain(Purkinje cell) of Thy1CreERT2/+;Rosa26 tdTomato/+ mice
Fig4. Detection of tdTomato(red) in various tissues of Thy1CreERT2/+;Rosa26 tdTomato/+ mouse.
Organs and tissues with tdTomato expression following tamoxifen induction include: brain, spinal cord, large intestine, small intestine, stomach, liver, heart, lungs, salivary glands, spleen, skin, pancreas, reproductive system, adrenal glands, kidneys, thymus, and eyeballs.
Tissues with expression leakage in the uninduced group include: brain, salivary glands, skin, reproductive system, and eyes (retina).(119-days old, female and male) (For more detailed information please contact our technical advisor.)
你也可能感兴趣
Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
查看Workshop：Progress and Advances in Preclinical immuno-Oncology Research
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.
查看Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!
At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
查看
